Effect of Abciximab Therapy in Patients Undergoing Coronary Angioplasty for Acute ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock.

CONCLUSIONS: Patients with STEMI complicated by CS undergoing PCI treated with or without abciximab have similar 1-year survival rates; age, final TIMI 0-1 and oro-tracheal intubation are predictors of death. PMID: 25912694 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25912694?dopt=Abstract

Source: Circulation Journal - April 24, 2015 Category: Cardiology Authors: De Felice F, Tomassini F, Fiorilli R, Gagnor A, Parma A, Cerrato E, Musto C, Nazzaro MS, Varbella F, Violini R Tags: Circ J Source Type: research